US · Healthcare · Medical Instruments & Supplies
EPS came in at 0.13 against a street estimate of 0.09 — a beat of 46.3%.
with an average price target of $24.55.
| Fund | Stake |
|---|---|
| Massachusetts Financial Services Company | 2.45% |
| Longaeva Partners L.P. | 1.13% |
| Millennium Management LLC | 1.09% |
| Citadel Advisors Llc | 1.02% |
| Sessa Capital, L.P | 0.71% |
| Alyeska Investment Group, L.P. | 0.71% |
| NORGES BANK | 0.70% |
| Rock Springs Capital Management LP | 0.54% |
| Document | Date |
|---|---|
| Quarterly report · Q3 2026 MINIMED GROUP, INC. – Q1 FY2027 10-Q SUMMARY --- HEADLINE NUMBERS • Net sales: $843 million (Q1 FY2027) vs. $723 million (Q1 FY2026) – 16.6% growth | 2026-09-08 |
| Results announced · Q3 2026 MINIMED Q1 FY2027 EARNINGS SUMMARY HEADLINE NUMBERS • Net sales of $843 million, up 17% as reported and 16% organic year-over-year • U.S. net sales | 2026-09-01 |
| Proxy statement · Q4 2026 MINIMED GROUP, INC. – 2026 PROXY STATEMENT SUMMARY WHAT SHAREHOLDERS ARE VOTING ON • Proposal 1 (Election of Directors): Vote to elect four Class I | 2026-08-21 |
| Board / officer change · Q3 2026 MINIMED GROUP, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • No financial metrics provided in this filing • Document dated July 30, 2026 (earliest even | 2026-08-05 |
| Annual report FY2026 MINIMED GROUP, INC. – FORM 10-K SUMMARY FOR FISCAL YEAR ENDED APRIL 24, 2026 HEADLINE NUMBERS • Company: MiniMed Group, Inc., traded as MMED on Nasd | 2026-06-29 |
| Board / officer change · Q2 2026 MINIMED GROUP, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Board size increased from 9 to 11 directors (2 new appointments effective June 29, 2026) • | 2026-06-29 |
| Results announced · Q2 2026 MINIMED Q4 FY2026 EARNINGS SUMMARY HEADLINE NUMBERS • Q4 FY2026 net sales: $837 million, up 16% reported / 9% organic year-over-year • Full fiscal y | 2026-06-03 |
| Quarterly report · Q1 2026 MINIMED GROUP, INC. - QUARTERLY SUMMARY (Q3 FY2026) HEADLINE NUMBERS • Net Sales (9 months ended Jan 23, 2026): $2,265 million vs. $1,991 million (p | 2026-04-17 |
Readable in the app.
| Announcement | Date |
|---|---|
| FDA clears next-generation insulin pump for earlier commercialization MiniMed Group announced FDA clearance of its MiniMed Flex, a smartphone-controlled insulin pump, several months ahead of schedule. This is positive for commercialization timing. However, the | 2026-03-25 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for MiniMed Group, Inc. Common Stock — free to start.
Google PlayApp StoreData updated 2026-09-18.